Our Leadership

Robert W. Rubin, Ph.D.
Chief Executive Officer
Shannon L. Toma
Executive Vice President, Chief Operating Officer
Steven Belinsky, PhD
Vice President forResearch/Professor

Edward G. Barrett, Ph.D.
Senior Director, Pharmacology
Philip J. Kuehl, Ph.D.
Senior Director of Non-Clinical Drug Development & Head of Commercial Business Development
Melanie Doyle-Eisele, Ph.D.
Senior Director of Life Sciences & Head of Federal Business Development
Theodore (Ted) W. Sanders Jr., DVM, MS, MBA, DACLAM
Director Comparative Medicine & Attending Veterinarian
Nandakumar Ranganathan
Senior Director of Information Technology
Dale Mack
Senior Director, Facility Operations & Radiation Safety Officer
Dr. Doyle-Eisele is a Senior Scientist and the Senior Director of Laboratory Animal Sciences (Life Sciences) at Lovelace Biomedical Research Institute/Lovelace Biomedical. In this capacity, she oversees the major areas of research in the Applied Sciences Division. Her main research emphasis areas intersect Drug Development from early model evaluation to completion of Investigational New Drug/New Drug Applications and Emergency Use Authorizations. Much of this work is in the CBRNE arena. This is conducted through her expertise in pharmacokinetics, pharmacology, toxicology, and specialized capabilities in pulmonary disease, infectious disease, inflammation, and injury. Her division has developed animal models of inflammation (pulmonary/other), acute distress and nervous system (primarily chemical and toxin injury), disposition (ADME and radionuclide models), toxicology (IND/NDA enabling and exploratory), radiation-induced injury (hematopoietic, gastrointestinal, and dermal), chemical injury, and infectious disease (select agent and non-select agent). Dr. Doyle-Eisele oversees Study Directors and technical staff with expertise in each of these research areas. Dr. Doyle-Eisele received a B.S. in chemistry from the University of South Carolina and an MS & Ph.D. in inhalation toxicology and environmental chemistry from the University of North Carolina. Dr. Doyle-Eisele joined Lovelace in 2007.”